Details

Autor(en) / Beteiligte

• Feitosa, Fabiana G A M
• Feitosa, Audes D M
• Paiva, Annelise M G
• Mota-Gomes, Marco A
• Barroso, Weimar S
• Miranda, Roberto D
• Barbosa, Eduardo C D
• Brandão, Andréa A
• Lima-Filho, José L
• Sposito, Andrei C
• Coca, Antonio
• Nadruz, Jr, Wilson

Titel

Impact of the COVID-19 pandemic on blood pressure control: a nationwide home blood pressure monitoring study

Ist Teil von

• Hypertension research, 2022-02, Vol.45 (2), p.364-368

Ort / Verlag

England: Nature Publishing Group

Erscheinungsjahr

2022

Quelle

MEDLINE

Beschreibungen/Notizen

• There are concerns that hypertension control may decrease during the COVID-19 pandemic. This study evaluated the impact of the COVID-19 pandemic on office blood pressure (OBP) and home blood pressure monitoring (HBPM) control in a large Brazilian nationwide sample. The results of an adjusted spline analysis evaluating the trajectory of OBP and HBPM control from 01/Jan/2019 to 31/Dec/2020 among independent participants who were untreated (n = 24,227) or treated (n = 27,699) with antihypertensive medications showed a modest and transient improvement in OBP control among treated individuals, which was restricted to the early months following the COVID-19 pandemic outbreak. Furthermore, slight reductions in OBP and HBPM values were detected in the early months following the COVID-19 pandemic outbreak among treated (n = 987) participants for whom blood pressure measurements before and during the pandemic were available, but not among untreated (n = 495) participants. In conclusion, we found no major adverse influence of the COVID-19 pandemic on OBP and HBPM control in a large nationwide sample.